Target intelligence / Profile preview

Immune system modulation via secretome, extracellular vesicles, and cell-contact

Molecular classification
Other
01

Overview

This concept describes the three primary modes of communication used by the immune system to coordinate population-level responses and maintain homeostasis. The secretome consists of soluble proteins like cytokines and chemokines that act over distances to recruit and activate cells (Buzas, 2023, Nature Reviews Immunology). Extracellular vesicles (EVs), such as exosomes, serve as complex delivery vehicles for proteins, lipids, and nucleic acids, allowing for the transfer of functional information between cells (Buzas, 2023; MDPI, 2021, Biology). Direct cell-contact involves physical interactions at the immunological synapse, where surface receptors and ligands (e.g., TCR-MHC or PD-1/PD-L1) dictate cell fate and activity (MDPI, 2021). Together, these mechanisms are critical for mounting effective immune responses against pathogens and are frequently dysregulated in conditions such as cancer, where they are targeted by therapies like checkpoint inhibitors and cytokine blockers (Buzas, 2023; Oxford Academic, 2019, Stem Cells Translational Medicine). This integrated network allows for the collective modulation of immune cell phenotypes, shifting populations between pro-inflammatory and regulatory states.

Other names
Immune cell crosstalkIntercellular communication in the immune systemImmune secretome and vesicle signalingJuxtacrine and paracrine immune regulation
02

Mechanism of action

Modulation of immune cell populations through the secretion of soluble mediators (cytokines/chemokines), the release of extracellular vesicles (exosomes/microvesicles) containing bioactive cargo, and direct physical cell-to-cell interactions (receptor-ligand binding).

03

Biological functions

Immune responseSignal transductionCell-cell communicationImmunomodulationCellular homeostasis
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionNeurodegenerative disease
05

Safety considerations

Cytokine release syndromeSystemic immunosuppressionOff-target effects of vesicle cargoAutoimmunityInfusion reactions
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Circulating cytokine levels (e.g., IL-6, TNF-alpha)Exosomal microRNA profilesSurface marker expression (e.g., PD-L1, CD80/86)Extracellular vesicle concentration

Beyond the preview

Go deeper on Immune system modulation via secretome, extracellular vesicles, and cell-contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system modulation via secretome, extracellular vesicles, and cell-contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call